ZyVersa Therapeutics, a biopharmaceutical company, has filed a Form 424B5 with the Securities and Exchange Commission. This filing is typically associated with the registration of securities for a company's public offering. The document, identified as form424b5.htm, indicates that ZyVersa Therapeutics is potentially preparing to offer securities to investors, although the specific details of the offering such as the type of securities, the amount, and the timing were not disclosed in the provided announcement text.

ZyVersa Therapeutics, a biopharmaceutical company, has filed a Form 424B5 with the Securities and Exchange Commission. This filing is typically associated with the registration of securities for a company's public offering. The document, identified as form424b5.htm, indicates that ZyVersa Therapeutics is potentially preparing to offer securities to investors, although the specific details of the offering such as the type of securities, the amount, and the timing were not disclosed in the provided announcement text.